Micromet Inactive 10-K2008 FY Annual report

Filed: 16 Mar 09, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: accompanyingManagement, adequacy, attainment, behaved, Biology, blinatumomab, categorized, circumvention, conference, consecutive, daily, decisionmaking, deconsolidated, deconsolidation, Eisai, enzyme, epithelium, explain, feasibility, hairy, hard, headcount, hiding, hierarchy, IgE, immaterial, Importantly, indirectly, injected, inside, left, lowest, magazine, meter, microgram, middle, MSCP, newer, noncontrolling, ofScience, orderly, Overview, path, perspective, pharmacodynamic, pharmacokinetic, prolymphocytic, Ratification, reacquire, resection, Schering, subform, threshold, tiered, traditionally, unadjusted, unchanged, undisclosed, unobservable

Removed: absence, amortize, announced, announcement, bank, borrow, calculating, Canadian, carry, chemotherapeutic, CIMAB, clinic, close, closure, CNVX, combating, complementary, confidence, considerably, consummated, consummation, conversion, Cuban, customary, cytotoxic, destruction, discounted, display, dispute, diverse, economic, effected, Eli, enrollment, environment, epidermal, FAS, fashion, flexibility, focused, forma, FSP, fulfill, gene, Genentech, generation, humanize, humoral, implement, implementation, implemented, increasingly, inhibitor, insolvency, instance, involvement, iv, kill, kinase, lapatinib, leverage, leveraged, Lilly, listing, Mexico, murine, opposed, organization, paclitaxel, par, pathway, percent, prevail, pro, processing, produced, prospective, quickly, recognizing, recruit, refer, regimen, relocation, renal, rental, representative, requested, restructuring, reverse, revoked, satisfy, secured, shelf, Silicon, submitted, subsequently, suffered, surviving, tasked, transition, trastuzumab, tyrosine, unpaid, updating, upgrade, USC, vaccine, Valley, variable, violation, warehouse, world, YM, Zealand

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Micromet similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATIONS OF

PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Micromet, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christian Itin, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Report and results of operations of the Company for the period covered by the Report.


Date: March 16, 2009	/s/ Christian Itin
	Christian Itin
	President and Chief Executive Officer
	(principal executive officer)

This certification accompanies the Report and shall not be deemed “filed” by the Company with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.

In connection with the Annual Report of Micromet, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Barclay A. Phillips, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


Date: March 16, 2009	/s/ Barclay A. Phillips
	Barclay A. Phillips
	Senior Vice President and Chief Financial Officer
	(principal financial officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.